This study assesses the therapeutic efficiency of the antidepressant Venlaxor (Venlafaxinum) in the complex treatment of affective disorders of the alcoholics suffering repetitive alcoholic psychosis. Concluded in 2008, the one-year study of two groups of 112 patients, men 25-55 years of age diagnosed with chronic alcoholism of 5-15 years, who were treated in the Psychiatric Clinical Hospital of Chisinau. The study showed the efficiency of Venlaxor in the treatment of affective disorders of alcoholic patients given the daily dose of 75-100 mg taken for periods up to two months. It can be recommended as a first-choice medication in diminishing pathological alcoholic addiction throughout the period of therapeutic remission.
A fost evaluat efectul terapeutic al Venlaxorului la pacienţii cu dereglări afective în etilismul cronic, complicat prin psihoze alcoolice repetate. Studiul a cuprins un eşantion constituit din 112 bolnavi – bărbaţi cu vârste de la 25 până la 55 de ani; spitalizaţi în Clinica Psihiatrie, mun. Chişinău. Conform rezultatelor obţinute, Venlaxorul posedă acţiune antidepresivă, la pacienţii care au suportat psihoze alcoolice; este recomandat în doze nictemerale de la 75 până la 150 mg în remisiunile alcoolismului cronic.
